您的位置:首页 > 产品中心 > 123021-85-2, GPR35 Agonist, Compound 10
GPR35 Agonist, Compound 10
产品别名
123021-85-2
GPR35 Agonist, Compound 10
2-[4-[(2,4-Dioxo-5-thiazolidinylidene)methyl]phenoxy]-acetic acid
结构式
基本信息
Empirical Formula【经验(实验)分子式】 | C12H9NO5S |
Molecular weight | 279.27 |
MDL number | MFCD01835940 |
PubChem Substance ID【PubChem化学物质编号】 | 329825204 |
NACRES | NA.77 |
Application【应用】 | GPR35 Agonist, Compound 10, may be used in GPR35-mediated cell signaling studies. |
Biochem/physiol Actions【生化/生理作用】 | GPR35 agonist Compound 10 is a GPR35 agonist the binds with higher affinity than other known agonists, such as kynurenic acid and zaprinast. Compound 10 was more potent than zaniprast (pEC50 = 5.3 vs 4.18) for recombinantly expressed human GPR35, and unlike zaprinast, is equipotent for human and rat GPR35 |
产品性质
Quality Level【质量水平】 | 100 |
Assay【测定】 | ≥98% (HPLC) |
form【形式】 | powder |
color【颜色】 | white to tan |
solubility【溶解性】 | DMSO: ≥5 mg/mL at ~60 ℃ |
storage temp.【储存温度】 | 2-8℃ |
SMILES string | OC(=O)COc1ccc(cc1)\C=C2/SC(=O)NC2=O |
InChI | 1S/C12H9NO5S/c14-10(15)6-18-8-3-1-7(2-4-8)5-9-11(16)13-12(17)19-9/h1-5H,6H2,(H,14,15)(H,13,16,17)/b9-5- |
InChI key | WXMCOLGPDOYHNK-UITAMQMPSA-N |
packaging【包装】 | 5, 25 mg in glass bottle |
安全信息
Pictograms【象形图】 | GHS07 |
Signal word【警示用语:】 | Warning |
Hazard Statements | H319 |
Precautionary Statements | P305 + P351 + P338 |
Hazard Classifications【危险分类】 | Eye Irrit. 2 |
Storage Class Code【储存分类代码】 | 13 - Non Combustible Solids |
WGK | WGK 3 |